A detailed history of Promus Capital, LLC transactions in Stryker Corp stock. As of the latest transaction made, Promus Capital, LLC holds 604 shares of SYK stock, worth $217,518. This represents 0.14% of its overall portfolio holdings.

Number of Shares
604
Holding current value
$217,518
% of portfolio
0.14%

Shares

3 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2025

Nov 13, 2025

BUY
$368.57 - $403.53 $222,616 - $243,732
604 New
604 $223 Million
Q1 2025

Aug 25, 2025

BUY
$355.18 - $399.9 $213,463 - $240,339
601 New
601 $224 Million
Q4 2024

Aug 25, 2025

BUY
$345.14 - $392.15 $207,084 - $235,290
600 New
600 $216 Million

Others Institutions Holding SYK

About STRYKER CORP


  • Ticker SYK
  • Exchange NYSE
  • Sector Healthcare
  • Industry Medical Devices
  • Shares Outstandng 378,320,992
  • Market Cap $136B
  • Description
  • Stryker Corporation operates as a medical technology company. The company operates through two segments, MedSurg and Neurotechnology, and Orthopaedics and Spine. The Orthopaedics and Spine segment provides implants for use in hip and knee joint replacements, and trauma and extremities surgeries. This segment also offers spinal implant products c...
More about SYK
Track This Portfolio

Track Promus Capital, LLC Portfolio

Follow Promus Capital, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Promus Capital, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Promus Capital, LLC with notifications on news.